Marijuana
Post Traumatic Stress Disorder
OMNI Medical Services, LLCPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 89/ 100
Competitive context
7 Active assets in the Post Traumatic Stress Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE Queen's University | Phase 4 | BBB |
Cipralex New York State Psychiatric Institute | Phase 4 | BB |
Fycompa Yale University | Phase 2 | B |
Alto-100 Po Alto Neuroscience | Phase 2 | B |
Alto-100 Alto Neuroscience | Phase 2 | B |
View all 11 →
Same molecule, other indications
Marijuana is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →